SLE vs OPRA

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 13, 2026

SLE

36.1
AI Score
VS
SLE Wins

OPRA

31.2
AI Score

Investment Advisor Scores

SLE

36score
Recommendation
SELL

OPRA

31score
Recommendation
SELL

AI Analyst Insights

Detailed Metrics Comparison

Metric SLE OPRA Winner
Forward P/E 0 0 Tie
PEG Ratio 0 0 Tie
Revenue Growth 10.5% 23.2% OPRA
Earnings Growth 0.0% 35.0% OPRA
Tradestie Score 36.1/100 31.2/100 SLE
Profit Margin -176.6% 17.7% OPRA
Beta 1.00 1.00 Tie
AI Recommendation SELL SELL Tie

Relative Price Performance (Last 90 Days)

SLE 1M: +49.8% · 3M: -18.9% OPRA 1M: +4.9% · 3M: +8.2%

Current Technical Phase

SLE

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 56

RSI (14): 56.5 · Price: $4.03

OPRA

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 47

RSI (14): 46.6 · Price: $18.96

Fundamentals Snapshot

Metric SLE OPRA
Market Cap
Forward P/E -1.3 10.7
Trailing P/E 0.0 13.2
Revenue (TTM)
Revenue Growth 0.1% 0.2%
Gross Margin 0.4% 0.5%
Operating Margin -1.4% 0.2%
EPS 123.94 1.39
Dividend Yield 0.04%

Frequently Asked Questions

Based on our detailed analysis, SLE is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.